Jones Trading reiterated a Buy rating on ORIC Pharmaceuticals stock with a price target of $17.00, as shares traded at $11.23. The stock has shown remarkable momentum, gaining over 20% in the past ...

Landmark single-cell dataset of one billion cells will be used to train new AI models to advance understanding of cellular ...

Research from Umeå University paves the way for a quantitative data analysis method to study the cell division process in ...

This important study focused on characterizing clonally derived MSC populations from the synovium of normal and osteoarthritis (OA) patients, demonstrating their potential to regenerate cartilage in ...

Objective Neural tube defects (NTDs) are a preventable folate deficiency disorder; increasing folic acid intake through food ...

This important study demonstrates the potential of synthetic gene circuits to detect and target aberrant RAS activity in cancer cell lines. The circuit design is novel and the evidence supporting the ...

Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...

New Jersey’s Indiscriminate Prosecution of Children as Adults,” reveals that prosecutors have near-total discretion to decide ...

Background The Prognostic Nutritional Index (PNI), calculated from serum albumin levels and lymphocyte counts, is a simple ...

Jan. 28, 2025 — A team of stem cell scientists have successfully used embryonic stem cell engineering to create a bi-paternal mouse -- a mouse with two male parents -- that lived until adulthood.

You can read more about the model at the bottom of the page. The projections will be updated regularly throughout each week.